Challenges of community point-of-care antibody testing for COVID-19 herd-immunity in Japan-Reference-Cited by-同舟云学术

Challenges of community point-of-care antibody testing for COVID-19 herd-immunity in Japan

Published:2020-05-28 Issue:11 Volume:113 Page:785-786
ISSN:1460-2725
Container-title:QJM: An International Journal of Medicine
language:en
Short-container-title:

Author:

Takita M¹^ORCID,Matsumura T¹,Yamamoto K¹²³,Yamashita E²,Hosoda K⁴,Hamaki T²,Kusumi E¹²

Affiliation:

1. From the Department of Internal Medicine, Navitas Clinic Tachikawa, 3-1-1 Shibasaki 4th floor of Ecute Tachikawa Bldg, Tachikawa, Tokyo 190-0023, Japan

2. Department of Internal Medicine, Navitas Clinic Shinjuku, 4-1-6 Shinjuku 7th floor of Newoman Bldg, Shinjuku, Tokyo 160-0022, Japan

3. Department of Reproductive, Developmental and Aging Sciences, Graduate School of Medicine, University of Tokyo, 4-6-1 Shirokanedai, Minato, Tokyo 108-0071, Japan

4. Department of Pediatrics, Navitas Clinic Tachikawa, 3-1-1 Shibasaki 4th floor of Ecute Tachikawa Bldg, Tachikawa, Tachikawa, Tokyo 190-0023, Japan

Funder

Navitas Clinic

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/qjmed/advance-article-pdf/doi/10.1093/qjmed/hcaa182/33440395/hcaa182.pdf

Reference7 articles.

1. COVID-19: how Japan squandered its early jump on the pandemic;Hayasaki;BMJ,2020

2. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies;Montesinos;J Clin Virol,2020

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing national border reopening policies in the COVID-19 pandemic: A modeling study;Frontiers in Public Health;2022-11-30

2. Seroprevalence of antibodies to SARS‐CoV‐2 in healthcare workers in a nonepidemic region, Japan: A hospital‐based study on May, 2020;Journal of Medical Virology;2021-04-03

3. Measuring the Serologic Response to Severe Acute Respiratory Syndrome Coronavirus 2;Clinics in Laboratory Medicine;2020-12

4. Serological Tests for SARS-CoV-2 Coronavirus by Commercially Available Point-of-Care and Laboratory Diagnostics in Pre-COVID-19 Samples in Japan;Diseases;2020-09-23

5. Serological Tests for SARS-CoV-2 Coronavirus by Commercially Available Point-of-Care and Laboratory Diagnostics in Pre-COVID-19 Samples in Japan;2020-07-11